KURA (STOCKS)
Kura Oncology, Inc.
$8.720000
+0.050000 (+0.58%)
Prev close: $8.670000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Troy E. Wilson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $769.35M
- Employees
- 192
- P/E (TTM)
- -2.74
- P/B (TTM)
- 4.37
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
12
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.92 | $-0.49 | -0.4254 | -86.01% |
|
Sep 2025 (Q3)
|
$-0.85 | $-0.87 | +0.0188 | +2.16% |
|
Jun 2025 (Q2)
|
$-0.75 | $-0.47 | -0.2819 | -60.22% |
|
Mar 2025 (Q1)
|
$-0.66 | $-0.40 | -0.2614 | -65.58% |
Financial Statements
| Revenues | $67.48M |
| Benefits Costs and Expenses | $345.85M |
| Costs And Expenses | $345.85M |
| Nonoperating Income/Loss | $25.26M |
| Operating Expenses | $371.11M |
| Selling, General, and Administrative Expenses | $119.98M |
| Research and Development | $251.07M |
| Other Operating Expenses | $57.00K |
| Operating Income/Loss | -$303.63M |
| Income/Loss From Continuing Operations After Tax | -$278.67M |
| Income/Loss From Continuing Operations Before Tax | -$278.37M |
| Income Tax Expense/Benefit | $297.00K |
| Net Income/Loss | -$278.67M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$278.67M |
| Net Income/Loss Available To Common Stockholders, Basic | -$278.67M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.18 |
| Diluted Earnings Per Share | -$3.18 |
| Basic Average Shares | 87,676,000 |
| Diluted Average Shares | 87,676,000 |
| Assets | $738.36M |
| Current Assets | $708.66M |
| Inventory | $413.00K |
| Other Current Assets | $708.25M |
| Noncurrent Assets | $29.70M |
| Fixed Assets | $7.86M |
| Other Non-current Assets | $21.85M |
| Liabilities | $564.23M |
| Current Liabilities | $116.97M |
| Accounts Payable | $5.02M |
| Wages | $22.37M |
| Other Current Liabilities | $89.59M |
| Noncurrent Liabilities | $447.25M |
| Long-term Debt | $9.70M |
| Other Non-current Liabilities | $437.55M |
| Equity | $174.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $174.14M |
| Liabilities And Equity | $738.36M |
| Net Cash Flow From Operating Activities | -$64.06M |
| Net Cash Flow From Operating Activities, Continuing | -$64.06M |
| Net Cash Flow From Investing Activities | -$13.10M |
| Net Cash Flow From Investing Activities, Continuing | -$13.10M |
| Net Cash Flow From Financing Activities | $1.79M |
| Net Cash Flow From Financing Activities, Continuing | $1.79M |
| Net Cash Flow | -$75.36M |
| Net Cash Flow, Continuing | -$75.36M |
| Comprehensive Income/Loss | -$278.41M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$278.41M |
| Other Comprehensive Income/Loss | $260.00K |